| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection.
|
N Engl J Med
|
2009
|
14.31
|
|
2
|
Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection.
|
Am J Gastroenterol
|
2002
|
8.21
|
|
3
|
Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial.
|
Lancet
|
2010
|
6.52
|
|
4
|
Long-term safety of lamivudine treatment in patients with chronic hepatitis B.
|
Gastroenterology
|
2003
|
4.33
|
|
5
|
Histological outcome during long-term lamivudine therapy.
|
Gastroenterology
|
2003
|
3.88
|
|
6
|
Hepatitis C virus infection in USA: an estimate of true prevalence.
|
Liver Int
|
2011
|
3.36
|
|
7
|
A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2008 update.
|
Clin Gastroenterol Hepatol
|
2008
|
2.97
|
|
8
|
Epoetin alfa maintains ribavirin dose in HCV-infected patients: a prospective, double-blind, randomized controlled study.
|
Gastroenterology
|
2004
|
2.28
|
|
9
|
A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: an update.
|
Clin Gastroenterol Hepatol
|
2006
|
1.92
|
|
10
|
Tenofovir disoproxil fumarate (TDF), emtricitabine/TDF, and entecavir in patients with decompensated chronic hepatitis B liver disease.
|
Hepatology
|
2010
|
1.79
|
|
11
|
A dose-ranging study of the efficacy and tolerability of entecavir in Lamivudine-refractory chronic hepatitis B patients.
|
Gastroenterology
|
2005
|
1.76
|
|
12
|
Outcomes of liver transplantation in patients with cirrhosis due to nonalcoholic steatohepatitis versus patients with cirrhosis due to alcoholic liver disease.
|
Liver Transpl
|
2009
|
1.67
|
|
13
|
Predictors of HBeAg loss after lamivudine treatment for chronic hepatitis B.
|
Hepatology
|
2002
|
1.60
|
|
14
|
Spontaneous clearance of hepatitis C virus after liver transplantation in two patients coinfected with hepatitis C virus and human immunodeficiency virus.
|
Liver Transpl
|
2008
|
1.59
|
|
15
|
A treatment algorithm for the management of chronic hepatitis B virus infection in the United States.
|
Clin Gastroenterol Hepatol
|
2004
|
1.47
|
|
16
|
Oral IDN-6556, an antiapoptotic caspase inhibitor, may lower aminotransferase activity in patients with chronic hepatitis C.
|
Hepatology
|
2007
|
1.38
|
|
17
|
Acetaminophen safety and hepatotoxicity--where do we go from here?
|
Expert Opin Drug Saf
|
2007
|
1.36
|
|
18
|
Alcohol and hepatitis C.
|
Semin Liver Dis
|
2004
|
1.34
|
|
19
|
Epoetin alfa improves quality of life in anemic HCV-infected patients receiving combination therapy.
|
Hepatology
|
2004
|
1.30
|
|
20
|
Hepatitis B virus reactivation after cytotoxic chemotherapy: the disease and its prevention.
|
Clin Gastroenterol Hepatol
|
2006
|
1.21
|
|
21
|
The influence of menopause on the development of hepatic fibrosis in nonobese women with nonalcoholic fatty liver disease.
|
Hepatology
|
2014
|
1.17
|
|
22
|
Colchicine treatment of alcoholic cirrhosis: a randomized, placebo-controlled clinical trial of patient survival.
|
Gastroenterology
|
2005
|
1.15
|
|
23
|
The current economic burden of cirrhosis.
|
Gastroenterol Hepatol (N Y)
|
2011
|
1.11
|
|
24
|
Statins in the treatment of dyslipidemia in the presence of elevated liver aminotransferase levels: a therapeutic dilemma.
|
Mayo Clin Proc
|
2010
|
1.06
|
|
25
|
Does the heterozygous state of alpha-1 antitrypsin deficiency have a role in chronic liver diseases? Interim results of a large case-control study.
|
J Pediatr Gastroenterol Nutr
|
2006
|
1.01
|
|
26
|
Comparison of three commercially available assays for HCV RNA using the international unit standard: implications for management of patients with chronic hepatitis C virus infection in clinical practice.
|
Am J Gastroenterol
|
2003
|
1.00
|
|
27
|
Orthotopic liver transplantation in patients with human immunodeficiency virus and end-stage liver disease.
|
Liver Transpl
|
2003
|
0.97
|
|
28
|
A United States compassionate use study of lamivudine treatment in nontransplantation candidates with decompensated hepatitis B virus-related cirrhosis.
|
Liver Transpl
|
2003
|
0.96
|
|
29
|
Treatment of established recurrent hepatitis C in liver-transplant recipients with pegylated interferon-alfa-2b and ribavirin therapy.
|
Transplantation
|
2004
|
0.94
|
|
30
|
Histopathological changes after microwave coagulation therapy for patients with hepatocellular carcinoma: review of 15 explanted livers.
|
Am J Gastroenterol
|
2003
|
0.91
|
|
31
|
Reliability of histopathologic assessment for the differentiation of recurrent hepatitis C from acute rejection after liver transplantation.
|
Liver Transpl
|
2004
|
0.91
|
|
32
|
A retrospective review of sirolimus (Rapamune) therapy in orthotopic liver transplant recipients diagnosed with chronic rejection.
|
Liver Transpl
|
2003
|
0.90
|
|
33
|
Multiple normal deliveries in a woman with severe portal hypertension due to congenital hepatic fibrosis: the importance of preserved hepatocellular function.
|
Am J Gastroenterol
|
2005
|
0.90
|
|
34
|
FibroSURE and FibroScan in relation to treatment response in chronic hepatitis C virus.
|
World J Gastroenterol
|
2011
|
0.90
|
|
35
|
Outcomes after orthotopic liver transplantation in 15 HIV-infected patients.
|
Transplantation
|
2007
|
0.89
|
|
36
|
Resistance-associated amino acid variants associated with boceprevir plus pegylated interferon-α2b and ribavirin in patients with chronic hepatitis C in the SPRINT-1 trial.
|
Antivir Ther
|
2013
|
0.88
|
|
37
|
Outcomes in liver transplant recipients with hepatitis B virus: resistance and recurrence patterns from a large transplant center over the last decade.
|
Liver Transpl
|
2004
|
0.88
|
|
38
|
Lamivudine monoprophylaxis for liver transplant recipients with non-replicating hepatitis B virus infection.
|
Clin Transplant
|
2007
|
0.86
|
|
39
|
Advances in hepatology: current developments in the treatment of hepatitis and hepatobiliary disease.
|
Gastroenterol Hepatol (N Y)
|
2009
|
0.86
|
|
40
|
Avoid the tragedy of hepatitis B reactivation in immunosuppressed patients.
|
Nat Clin Pract Gastroenterol Hepatol
|
2007
|
0.84
|
|
41
|
Histologic evidence of active liver injury in chronic hepatitis B patients with normal range or minimally elevated alanine aminotransferase levels.
|
J Clin Gastroenterol
|
2010
|
0.83
|
|
42
|
Predictors of cirrhosis in Hispanic patients with nonalcoholic steatohepatitis.
|
Dig Dis Sci
|
2006
|
0.83
|
|
43
|
An update on the hepatitis E virus.
|
Curr Gastroenterol Rep
|
2013
|
0.83
|
|
44
|
Prevention and treatment of recurrent Hepatitis B after liver transplantation: the current role of nucleoside and nucleotide analogues.
|
Ann Clin Microbiol Antimicrob
|
2006
|
0.81
|
|
45
|
Correlation of Laparoscopic Liver Biopsy to Elasticity Measurements (FibroScan) in Patients With Chronic Liver Disease.
|
Gastroenterol Hepatol (N Y)
|
2008
|
0.81
|
|
46
|
Diagnostic laparoscopy in radiation-induced liver disease.
|
Gastrointest Endosc
|
2002
|
0.81
|
|
47
|
Screening for hepatitis B virus and hepatitis C virus at a community fair: a single-center experience.
|
Gastroenterol Hepatol (N Y)
|
2013
|
0.80
|
|
48
|
Tenofovir therapy for lamivudine resistance following liver transplantation.
|
Ann Pharmacother
|
2004
|
0.80
|
|
49
|
Combined central retinal vein and central retinal artery occlusions and neovascular glaucoma associated with interferon treatment.
|
Eur J Ophthalmol
|
2012
|
0.80
|
|
50
|
Improved inflammatory activity with peginterferon alfa-2b maintenance therapy in non-cirrhotic prior non-responders: a randomized study.
|
J Hepatol
|
2012
|
0.79
|
|
51
|
Simvastatin-ezetimibe-induced hepatic failure necessitating liver transplantation.
|
Pharmacotherapy
|
2008
|
0.79
|
|
52
|
Prediction of sustained virological response in liver transplant recipients with recurrent hepatitis C virus following combination pegylated interferon alfa-2b and ribavirin therapy using tissue hepatitis C virus reverse transcriptase polymerase chain reaction testing.
|
Liver Transpl
|
2004
|
0.79
|
|
53
|
Acquired hepatocerebral degeneration in a patient with HCV cirrhosis: complete resolution with subsequent recurrence after liver transplantation.
|
Liver Transpl
|
2006
|
0.79
|
|
54
|
Prospective Evaluation of FIBROSpect II for Fibrosis Detection in Hepatitis C and B Patients Undergoing Laparoscopic Biopsy.
|
Gastroenterol Hepatol (N Y)
|
2007
|
0.78
|
|
55
|
Competing risks analysis of predictors of delisting owing to tumor progression in liver transplant candidates with hepatocellular carcinoma.
|
Am J Transplant
|
2004
|
0.78
|
|
56
|
Relapsing polychondritis, chronic hepatitis C virus infection, and mixed cryoglobulemia.
|
Semin Arthritis Rheum
|
2004
|
0.78
|
|
57
|
Chronic hepatitis B: a critical appraisal of current approaches to therapy.
|
Clin Gastroenterol Hepatol
|
2006
|
0.78
|
|
58
|
Recombinant leukocyte interferon, doxorubicin, and 5FUDR in patients with hepatocellular carcinoma-A phase II trial.
|
J Cancer Res Clin Oncol
|
2003
|
0.78
|
|
59
|
Clinical usage of serum ferritin to assess liver fibrosis in patients with non-alcoholic fatty liver disease: Proceed with caution.
|
Hepatol Res
|
2014
|
0.78
|
|
60
|
Imatinib mesylate (gleevec) hepatotoxicity.
|
Dig Dis Sci
|
2007
|
0.77
|
|
61
|
Beneficial effects of topical testosterone replacement in patients with end-stage liver disease.
|
Dig Dis Sci
|
2004
|
0.77
|
|
62
|
Focal nodular hyperplasia in identical twins.
|
Am J Gastroenterol
|
2005
|
0.77
|
|
63
|
High frequency of genotype D and spontaneous hepatitis B virus genomic mutations among Haitians in a multiethnic North American population.
|
J Clin Gastroenterol
|
2013
|
0.75
|
|
64
|
Decreasing Liver Stiffness Following Pericardiectomy for Constrictive Pericarditis.
|
Intern Med
|
2015
|
0.75
|
|
65
|
Budd-Chiari-like presentation of hepatic adenoma.
|
J Gastroenterol Hepatol
|
2005
|
0.75
|
|
66
|
Epithelioid hemangioendothelioma of the liver.
|
Clin Gastroenterol Hepatol
|
2005
|
0.75
|
|
67
|
Pretreatment laparoscopic appearance of the liver can predict response to combination therapy with interferon alpha 2B and ribavirin in chronic hepatitis C.
|
Gastrointest Endosc
|
2003
|
0.75
|
|
68
|
Professor Dame Sheila Sherlock (1918-2001).
|
Curr Opin Gastroenterol
|
2002
|
0.75
|